Document is current
Any future updates will be listed below
-
Authors
Kaufmann, Walter E. https://orcid.org/0000-0002-8561-8453
Raspa, Melissa
Bann, Carla M.
Gable, Julia M.
Harris, Holly K.
Budimirovic, Dejan B.
Lozano, Reymundo
,
Berry-Kravis, Elizabeth
Velinov, Milen
Talboy, Amy L
Sherman, Stephanie L
Kaufmann, Walter E
Schuster, Marcy
Tartaglia, Nicole
Filipink, Robyn A
Budimirovic, Dejan B
Barbouth, Deborah
Lightbody, Amy
Reiss, Allan
Delahunty, Carol M
Hagerman, Randi J
Hessl, David
Erickson, Craig A
Feldman, Gary
Picker, Jonathan D
Lachiewicz, Ave M
Harris, Holly K
Esler, Amy
Frye, Richard E
Evans, Patricia A
Morris, Mary Ann
Haas-Givler, Barbara A
Gropman, Andrea L
Uy, Ryan S
Buchanan, Carrie
Frazier, Jean A
Morris, Stephanie M
-
Funding
Funding for this research was provided by:
National Center on Birth Defects and Developmental Disabilities (U01DD000231)
National Center on Birth Defects and Developmental Disabilities (#U19DD000753)
National Center on Birth Defects and Developmental Disabilities (# U01DD001189)
National Center on Birth Defects and Developmental Disabilities (contract 75D30120F09737)
- License Information
-
More Information
Article History
Accepted: 7 November 2022
First Online: 28 November 2022
Declarations
:
: WEK is Chief Scientific Officer of Anavex Life Sciences Corp. HKH is a co-investigator on clinical trials funded by Ionis Pharmaceuticals, Neuren Pharmaceuticals and Clinical Research Associates, LLC. DBB has been principal investigator on clinical trials funded by Ovid Therapeutics and Zynerba Pharmaceuticals; he has also consulted for Ovid Therapeutics. The other co-authors declare that they have no competing interests.
: The Institutional Review Board at every participating site provided approval and oversight to ensure ethical conduct of human subjects research throughout the study. Informed consent was provided by all parents/guardians who participated. Consent or assent was provided by participants with fragile X syndrome, depending on age and consenting capacity as determined by the Institutional Review Boards.
